Olaf Schulz

Director of Venture Development and Zero-to-510

Olaf Schulz is a biomedical engineer with over 25 years in the medical device industry. Utilizing his expertise in full-cycle product development, he has overseen 27 product launches, which contributed to approximately more than $250 million in sales. He spent more than a decade at Wright Medical leading their hard-tissue biologics group. This was followed by work at several startups including Ariste Medical, where Olaf led the effort to secure FDA clearance for the company’s drug-eluting mesh product. Since 2019, Schulz has been actively involved in Zero-to-510, exercising his passion for mentoring startups and entrepreneurs as well as fostering growth and innovation in the Memphis medtech ecosystem.

4:10-5:00 p.m.

Wednesday April 24, 2024

Enabling Success: A Discussion of the New Technologies Transforming Orthopedics

Data-driven, AI-assisted, minimally invasive surgical technologies are revolutionizing the orthopedic device landscape. These enabling technologies include navigational systems, AR/VR equipment, robotic surgery solutions, among other offerings. What impact are these solutions having on the industry today? What will the impact be tomorrow? How will they change procedural techniques? What are the most important considerations when developing them? This panel discussion will tackle an array of questions around enabling technologies and what their future holds.

Moderated by David Sheppard